Deals of the day-Mergers and acquisitions

Reuters03-20 19:21
Deals of the day-Mergers and acquisitions

March 20 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1100 GMT on Friday:

** Unilever <ULVR.L> is in talks to sell its foods business to smaller rival McCormick & Company <MKC.N>, a potential deal that would unite the British company's Hellmann's and Knorr brands with the U.S. spice maker's Cholula hot sauce.

nL6N4080CJ

** Talks to sell Thyssenkrupp's <TKAG.DE> steel division to India's Jindal Steel International are not making progress and the long-awaited deal must not be stalled for months, the German company's deputy supervisory board chairman said.

nL8N4080BW

** British cross-border payments processor CAB Payments <CABP.L> said that it has rejected the recent all-cash offer from financial services firm StoneX <SNEX.O>, saying the proposal undervalues the company and its future prospects.

nL6N4080D7

** Buyout firm Bridgepoint <BPTB.L> is drawing up proposals for a formal offer worth more than 1 billion pounds ($1.34 billion) for British private hospital operator, Spire Healthcare <SPI.L>, Sky News reported on Thursday.

nL4N4072HX

** Swiss drugmaker Novartis NOVN.S agreed to buy a breast cancer drug candidate for up to $3 billion from U.S. biotech firm Synnovation Therapeutics, adding a targeted therapy to its pipeline of cancer drugs.

nL1N40807H

(Compiled by Rajarshi Roy and Dharna Bafna in Bengaluru)

((Rajarshi.Roy@thomsonreuters.com))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment